You have 9 free searches left this month | for more free features.

Head and Neck Squamous Cell Carcinoma

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Australia, Korea, Republic of, United States (TPX-0131)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Orange, California
  • +13 more
Nov 7, 2022

Renal Cell Carcinoma Trial in Scottsdale (questionnaire)

Completed
  • Renal Cell Carcinoma
  • questionnaire
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jun 15, 2020

Abdominal Aortic Aneurysm (AAA) Trial in Worldwide (endovascular repair of the AAA)

Recruiting
  • Abdominal Aortic Aneurysm (AAA)
  • endovascular repair of the AAA
  • Paris, France
  • +10 more
Jan 28, 2021

Immunological Pure Red Cell Aplasia Trial (Isatuximab)

Not yet recruiting
  • Immunological Pure Red Cell Aplasia
  • (no location specified)
Sep 26, 2022

Visualizing Beta Cells After Bariatric Surgery

Recruiting
  • Type 2 Diabetes Mellitus
  • 68Ga-exendin PET/CT
  • Arnhem, Gelderland, Netherlands
  • +1 more
Jun 16, 2022

Asthma, Allergic Trial in Boston (Bronchoscopy/BAL, Airway Brushing)

Recruiting
  • Asthma, Allergic
  • Bronchoscopy/BAL
  • Airway Brushing
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2022

Multi- Target Hepatocellular Carcinoma Test in Increased Risk

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Study CT/MRI Imaging
  • +2 more
  • Chandler, Arizona
  • +33 more
May 27, 2022

Lymphoma Trial in New York (rituximab, bendamustine, melphalan)

Active, not recruiting
  • Lymphoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 10, 2023

Leukemia, Myeloid, Acute Trial in Portugal, Spain (Pevonedistat, Azacitidine)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Coimbra, Portugal
  • +63 more
Sep 9, 2022

Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

Suspended
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Advanced Hepatocellular Carcinoma Trial (Adebrelimab, Bevacizumab, SHR-8068)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Jun 30, 2022

Late Dysphagia in Oropharynx and Nasopharynx Cancer, Candidates

Recruiting
  • Cancer of Oropharynx
  • Cancer of Nasopharynx
    • Pisa, Italy
      Azienda Ospedaliero Universitaria Pisana
    Jan 13, 2020

    Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • San Francisco, California
      University of California, San Francisco
    Dec 6, 2022

    Multiple Myeloma Trial in Birmingham (Multi-modal Exercise Regimen, Dietary Guidelines)

    Not yet recruiting
    • Multiple Myeloma
    • Multi-modal Exercise Regimen
    • Dietary Guidelines
    • Birmingham, Alabama
      Kirklin Clinic of UAB Hospital
    Nov 29, 2022

    Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)

    Enrolling by invitation
    • Peripheral T-cell Lymphoma Targeted Therapy
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Insititute & Hospital
    Jan 9, 2023

    Refractory Peripheral T-Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma Trial in Belgium, France (Brentuximab Vedotin -

    Completed
    • Refractory Peripheral T-Cell Lymphoma
    • Relapsed Peripheral T-Cell Lymphoma
    • Brentuximab Vedotin - induction
    • +3 more
    • Antwerpen, Belgium
    • +38 more
    Jan 9, 2023

    Recurrent Hepatocellular Carcinoma Trial in Guangzhou (Tislelizumab, Ablation)

    Recruiting
    • Recurrent Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    May 21, 2021

    Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

    Recruiting
    • Acute Myeloid Leukemia
    • Decitabine and Cedazuridine
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 10, 2022

    Diabetes, Diabetes, Proliferative Diabetic Retinopathy Trial in Aarhus

    Recruiting
    • Diabetes
    • +4 more
      • Aarhus, Denmark
        Steno Diabetes Center Aarhus, Aarhus University Hospiral
      Dec 23, 2021

      Postoperative Prevention of Tumor Trial in Shanghai (Oral NMN combined with DC cell vaccine)

      Not yet recruiting
      • Postoperative Prevention of Tumor
      • Oral NMN combined with DC cell vaccine
      • Shanghai, Shanghai, China
        Shanghai Mengchao Cancer Hospital
      Sep 6, 2023

      Hematopoietic and Lymphoid Cell Tumor Trial in United States (Best Practice and Internet site with links to existing resources,

      Active, not recruiting
      • Hematopoietic and Lymphoid Cell Neoplasm
      • Best Practice and Internet site with links to existing resources
      • +2 more
      • Tampa, Florida
      • +14 more
      Dec 5, 2022

      Imaging Order to 2020 French Guidelines for Cervical Spine

      Active, not recruiting
      • Cervical Spine Injury
        • Paris, France
          Groupe Hospitalier Paris Saint-Joseph
        Dec 8, 2022

        Locally Advanced or Metastatic Urothelial Carcinoma Trial in Spain (Atezolizumab 1200 mg/m2, Gemcitabine 1000 mg/m2, Cisplatin

        Active, not recruiting
        • Locally Advanced or Metastatic Urothelial Carcinoma
        • Atezolizumab 1200 mg/m2
        • +2 more
        • Barcelona, Spain
        • +11 more
        Mar 24, 2022

        Sickle Cell Disease Trial in Cairo (L-Glutamine, Oral Powder for Reconstitution, Standard of care)

        Recruiting
        • Sickle Cell Disease
        • L-Glutamine, Oral Powder for Reconstitution
        • Standard of care
        • Cairo, Non-US, Egypt
        • +1 more
        May 7, 2022

        Bronchiolitis Obliterans, Graft Vs Host Disease Trial in Palo Alto (Pirfenidone 267 MG [Esbriet])

        Completed
        • Bronchiolitis Obliterans
        • Graft Vs Host Disease
        • Pirfenidone 267 MG [Esbriet]
        • Palo Alto, California
          Stanford University School of Medicine
        Jun 8, 2022